FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

422264003: Powder for prolonged-release suspension for injection (dose form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3620912013 Powder for prolonged-release suspension for injection (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3620913015 Powder for prolonged-release suspension for injection en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3620914014 Powder for extended-release suspension for injection en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Powder for prolonged-release suspension for injection (dose form) Is a Powder for suspension for injection false Inferred relationship Some
Powder for prolonged-release suspension for injection (dose form) Is a Parenteral dose form (dose form) true Inferred relationship Some
Powder for prolonged-release suspension for injection (dose form) Has dose form administration method (attribute) Inject (administration method) true Inferred relationship Some
Powder for prolonged-release suspension for injection (dose form) Has dose form transformation (attribute) Disperse (transformation) true Inferred relationship Some
Powder for prolonged-release suspension for injection (dose form) Has dose form intended site (attribute) Parenteral (intended site) true Inferred relationship Some
Powder for prolonged-release suspension for injection (dose form) Has dose form release characteristic (attribute) Prolonged-release (release characteristic) true Inferred relationship Some
Powder for prolonged-release suspension for injection (dose form) Has basic dose form (attribute) Powder (basic dose form) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Lyophilized powder for prolonged-release suspension for injection Is a False Powder for prolonged-release suspension for injection (dose form) Inferred relationship Some
Risperidone 25 mg powder for prolonged-release suspension for injection vial Has manufactured dose form True Powder for prolonged-release suspension for injection (dose form) Inferred relationship Some
Product containing precisely risperidone 37.5 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection (dose form) Inferred relationship Some
Risperidone 50 mg powder for prolonged-release suspension for injection vial Has manufactured dose form True Powder for prolonged-release suspension for injection (dose form) Inferred relationship Some
Product containing precisely leuprorelin acetate 22.5 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection (dose form) Inferred relationship Some
Product containing precisely leuprorelin acetate 11.25 milligram/1 syringe powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection (dose form) Inferred relationship Some
Product containing precisely leuprorelin acetate 30 milligram/1 syringe powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection (dose form) Inferred relationship Some
Exenatide 2 mg powder for prolonged-release suspension for injection vial Has manufactured dose form True Powder for prolonged-release suspension for injection (dose form) Inferred relationship Some
Product containing precisely olanzapine (as olanzapine embonate) 405 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection (dose form) Inferred relationship Some
Olanzapine (as olanzapine embonate) 300 mg powder for prolonged-release suspension for injection vial Has manufactured dose form True Powder for prolonged-release suspension for injection (dose form) Inferred relationship Some
Product containing precisely olanzapine (as olanzapine embonate) 210 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection (dose form) Inferred relationship Some
Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection (dose form) Inferred relationship Some

This concept is not in any reference sets

Back to Start